Actively Recruiting
Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization
Led by University Hospital, Basel, Switzerland · Updated on 2025-02-25
480
Participants Needed
3
Research Sites
439 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is to evaluate the correlation between hs-cTn level as cardiac biomarker for ischemia and early graft occlusion as assessed by CCT in patients undergoing coronary bypass surgery.
CONDITIONS
Official Title
Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with isolated coronary bypass surgery
You will not qualify if you...
- Patients withholding or lacking informed consent
- Patients requiring a concomitant procedure
- Exclusion criteria concerning the CCT scan
- Patients with known allergy to iodine-containing contrast agents
- Renal function impairment (serum creatinine >140 mmol/l; estimated glomerular filtration rate <30 ml/min/1.73 m2)
- Pregnancy
- Unstable clinical state or severe heart failure
- Patients with registered myocardial infarction and registered bypass occlusion in coronary angiogram
- Patients that didn't undergo a CCT prior to discharge
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
University Hospital Centre Zagreb
Zagreb, Croatia, 10 000
Not Yet Recruiting
2
Wroclaw Medical University
Wroclaw, Borowska, Poland, 213
Not Yet Recruiting
3
Department for Cardiac Surgery, University Hospital Basel
Basel, Switzerland, 4031
Actively Recruiting
Research Team
D
Denis Berdajs, Prof. Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here